KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,395 | +35.4% | 11,879 | +26.5% | 0.00% | – |
| Q2 2023 | $84,483 | -28.9% | 9,387 | -37.9% | 0.00% | – |
| Q1 2023 | $118,867 | +69.1% | 15,123 | +45.4% | 0.00% | – |
| Q4 2022 | $70,304 | -52.8% | 10,400 | +1.6% | 0.00% | – |
| Q3 2022 | $149,000 | +41.9% | 10,238 | -3.7% | 0.00% | – |
| Q2 2022 | $105,000 | -44.4% | 10,633 | -17.3% | 0.00% | – |
| Q1 2022 | $189,000 | +1.6% | 12,852 | -8.7% | 0.00% | – |
| Q4 2021 | $186,000 | -32.1% | 14,078 | -10.4% | 0.00% | – |
| Q3 2021 | $274,000 | -5.2% | 15,708 | +29.9% | 0.00% | – |
| Q2 2021 | $289,000 | -9.7% | 12,091 | -3.1% | 0.00% | – |
| Q1 2021 | $320,000 | +57.6% | 12,475 | +16.5% | 0.00% | – |
| Q4 2020 | $203,000 | +113.7% | 10,712 | +41.0% | 0.00% | – |
| Q3 2020 | $95,000 | +15.9% | 7,596 | +12.6% | 0.00% | – |
| Q2 2020 | $82,000 | +148.5% | 6,747 | +55.6% | 0.00% | – |
| Q1 2020 | $33,000 | -59.3% | 4,336 | -5.7% | 0.00% | – |
| Q4 2019 | $81,000 | -19.8% | 4,598 | -47.5% | 0.00% | – |
| Q3 2019 | $101,000 | -50.5% | 8,757 | -5.7% | 0.00% | – |
| Q2 2019 | $204,000 | -59.8% | 9,286 | -47.8% | 0.00% | – |
| Q1 2019 | $508,000 | +16833.3% | 17,787 | +10424.9% | 0.00% | – |
| Q4 2018 | $3,000 | -99.2% | 169 | -99.0% | 0.00% | – |
| Q3 2018 | $358,000 | -12.5% | 16,187 | -67.9% | 0.00% | – |
| Q2 2018 | $409,000 | 0.0% | 50,461 | +16.7% | 0.00% | – |
| Q1 2018 | $409,000 | -50.1% | 43,245 | -48.5% | 0.00% | -100.0% |
| Q4 2017 | $819,000 | – | 84,004 | +1679980.0% | 0.00% | – |
| Q3 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |